High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation (Q44119543)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2002

Language	Label	Description	Also known as
English	High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation	scientific article published in August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

30 November 2017

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

author name string

Nakamura R

1

1 reference

Europe PubMed Central

30 November 2017

Cortez K

2

1 reference

Europe PubMed Central

30 November 2017

Solomon S

3

1 reference

Europe PubMed Central

30 November 2017

Battiwalla M

4

1 reference

Europe PubMed Central

30 November 2017

Gill VJ

5

1 reference

Europe PubMed Central

30 November 2017

Hensel N

6

1 reference

Europe PubMed Central

30 November 2017

Childs R

7

1 reference

Europe PubMed Central

30 November 2017

Barrett AJ

8

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

30 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

30 November 2017

30

1 reference

Europe PubMed Central

30 November 2017

4

1 reference

Europe PubMed Central

30 November 2017

235-242

1 reference

Europe PubMed Central

30 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703648

0 references

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703648

21 January 2018

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CMV reactivation in nonmyeloablative HSCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12203140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BMT.1703648

1 reference

Europe PubMed Central

30 November 2017

0 references

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44119543&oldid=2106779954"